Characteristic of Endometrial Stromal Sarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor
Curr Issues Mol Biol. 2023 Jul 25;45(8):6190-6201. doi: 10.3390/cimb45080390.ABSTRACTThe benign tumor uterine leiomyoma (UL) develops from the smooth muscle tissue that constitutes the uterus, whereas malignant tumor uterine sarcoma develops from either the smooth muscle tissue or stroma and is different from UL and endometrial cancer. Uterine sarcoma is broadly classified into three types: uterine leiomyosarcoma, endometrial stromal sarcoma (ESS), and carcinosarcoma. Although uterine leiomyosarcoma and ESS are both classified as uterine sarcoma, they significantly differ in terms of their sites of occurrence, symptoms, an...
Source: Current Issues in Molecular Biology - August 25, 2023 Category: Molecular Biology Authors: Takuma Hayashi Kenji Sano Nobuo Yaegashi Kaoru Abiko Ikuo Konishi Source Type: research
Characteristic of Endometrial Stromal Sarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor
Curr Issues Mol Biol. 2023 Jul 25;45(8):6190-6201. doi: 10.3390/cimb45080390.ABSTRACTThe benign tumor uterine leiomyoma (UL) develops from the smooth muscle tissue that constitutes the uterus, whereas malignant tumor uterine sarcoma develops from either the smooth muscle tissue or stroma and is different from UL and endometrial cancer. Uterine sarcoma is broadly classified into three types: uterine leiomyosarcoma, endometrial stromal sarcoma (ESS), and carcinosarcoma. Although uterine leiomyosarcoma and ESS are both classified as uterine sarcoma, they significantly differ in terms of their sites of occurrence, symptoms, an...
Source: Current Issues in Molecular Biology - August 25, 2023 Category: Molecular Biology Authors: Takuma Hayashi Kenji Sano Nobuo Yaegashi Kaoru Abiko Ikuo Konishi Source Type: research
Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma
CONCLUSIONS: Approximately 1 in 3 patients with uterine sarcoma harbor a pathogenic alteration in HR-DDR genes. Incidence is high among patients with uterine leiomyosarcoma and adenosarcoma.PMID:37611378 | DOI:10.1016/j.ygyno.2023.07.020 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - August 23, 2023 Category: Cancer & Oncology Authors: Dimitrios Nasioudis Nawar A Latif Emily M Ko Lori Cory Sarah H Kim Lainie Martin Fiona Simpkins Robert Giuntoli Source Type: research
Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma
CONCLUSIONS: Approximately 1 in 3 patients with uterine sarcoma harbor a pathogenic alteration in HR-DDR genes. Incidence is high among patients with uterine leiomyosarcoma and adenosarcoma.PMID:37611378 | DOI:10.1016/j.ygyno.2023.07.020 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - August 23, 2023 Category: Cancer & Oncology Authors: Dimitrios Nasioudis Nawar A Latif Emily M Ko Lori Cory Sarah H Kim Lainie Martin Fiona Simpkins Robert Giuntoli Source Type: research
Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma
CONCLUSIONS: Approximately 1 in 3 patients with uterine sarcoma harbor a pathogenic alteration in HR-DDR genes. Incidence is high among patients with uterine leiomyosarcoma and adenosarcoma.PMID:37611378 | DOI:10.1016/j.ygyno.2023.07.020 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - August 23, 2023 Category: Cancer & Oncology Authors: Dimitrios Nasioudis Nawar A Latif Emily M Ko Lori Cory Sarah H Kim Lainie Martin Fiona Simpkins Robert Giuntoli Source Type: research
Prevalence of sonographic signs in women with uterine sarcoma: a systematic review and meta-analysis
CONCLUSIONS: Solid component, irregular walls of cystic areas and singular lesions are signs at very high prevalence, while inhomogeneous echogenicity of solid component, anechoic cystic areas and absence of calcifications are signs at high prevalence. Remaining signs were less relevant.PMID:37562447 | DOI:10.1055/a-2151-9205 (Source: Ultraschall in der Medizin)
Source: Ultraschall in der Medizin - August 10, 2023 Category: Radiology Authors: Antonio Raffone Diego Raimondo Daniele Neola Antonio Travaglino Marisol Doglioli Marco Ambrosio Ivano Raimondo Lucia De Meis Luigi Carlo Turco Francesco Cosentino Renato Seracchioli Paolo Casadio Antonio Mollo Source Type: research
Prevalence of sonographic signs in women with uterine sarcoma: a systematic review and meta-analysis
CONCLUSIONS: Solid component, irregular walls of cystic areas and singular lesions are signs at very high prevalence, while inhomogeneous echogenicity of solid component, anechoic cystic areas and absence of calcifications are signs at high prevalence. Remaining signs were less relevant.PMID:37562447 | DOI:10.1055/a-2151-9205 (Source: Ultraschall in der Medizin)
Source: Ultraschall in der Medizin - August 10, 2023 Category: Radiology Authors: Antonio Raffone Diego Raimondo Daniele Neola Antonio Travaglino Marisol Doglioli Marco Ambrosio Ivano Raimondo Lucia De Meis Luigi Carlo Turco Francesco Cosentino Renato Seracchioli Paolo Casadio Antonio Mollo Source Type: research
Prevalence of sonographic signs in women with uterine sarcoma: a systematic review and meta-analysis
CONCLUSIONS: Solid component, irregular walls of cystic areas and singular lesions are signs at very high prevalence, while inhomogeneous echogenicity of solid component, anechoic cystic areas and absence of calcifications are signs at high prevalence. Remaining signs were less relevant.PMID:37562447 | DOI:10.1055/a-2151-9205 (Source: Ultraschall in der Medizin)
Source: Ultraschall in der Medizin - August 10, 2023 Category: Radiology Authors: Antonio Raffone Diego Raimondo Daniele Neola Antonio Travaglino Marisol Doglioli Marco Ambrosio Ivano Raimondo Lucia De Meis Luigi Carlo Turco Francesco Cosentino Renato Seracchioli Paolo Casadio Antonio Mollo Source Type: research
Prevalence of sonographic signs in women with uterine sarcoma: a systematic review and meta-analysis
CONCLUSIONS: Solid component, irregular walls of cystic areas and singular lesions are signs at very high prevalence, while inhomogeneous echogenicity of solid component, anechoic cystic areas and absence of calcifications are signs at high prevalence. Remaining signs were less relevant.PMID:37562447 | DOI:10.1055/a-2151-9205 (Source: Ultraschall in der Medizin)
Source: Ultraschall in der Medizin - August 10, 2023 Category: Radiology Authors: Antonio Raffone Diego Raimondo Daniele Neola Antonio Travaglino Marisol Doglioli Marco Ambrosio Ivano Raimondo Lucia De Meis Luigi Carlo Turco Francesco Cosentino Renato Seracchioli Paolo Casadio Antonio Mollo Source Type: research
Prevalence of sonographic signs in women with uterine sarcoma: a systematic review and meta-analysis
CONCLUSIONS: Solid component, irregular walls of cystic areas and singular lesions are signs at very high prevalence, while inhomogeneous echogenicity of solid component, anechoic cystic areas and absence of calcifications are signs at high prevalence. Remaining signs were less relevant.PMID:37562447 | DOI:10.1055/a-2151-9205 (Source: Ultraschall in der Medizin)
Source: Ultraschall in der Medizin - August 10, 2023 Category: Radiology Authors: Antonio Raffone Diego Raimondo Daniele Neola Antonio Travaglino Marisol Doglioli Marco Ambrosio Ivano Raimondo Lucia De Meis Luigi Carlo Turco Francesco Cosentino Renato Seracchioli Paolo Casadio Antonio Mollo Source Type: research
Clinical features of uterine sarcomas presenting mainly with uterine masses: a retrospective study
This study aims to investigate the clinical c... (Source: BMC Women's Health)
Source: BMC Women's Health - July 26, 2023 Category: OBGYN Authors: Menghan Zhu and Shouzhen Chen Tags: Research Source Type: research
The Application of 18F-FES PET in Clinical Cancer Care: A Systematic Review
CONCLUSIONS: [18F]fluoroestradiol PET is not only a convenient and accurate diagnostic imaging tool for detecting ER-expressing lesions in patients with breast and ovarian cancer but also among patients with uterine cancer. [18F]fluoroestradiol PET is a noninvasive predictive and monitoring tool for treatment response and prognosis.PMID:37482660 | DOI:10.1097/RLU.0000000000004760 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - July 24, 2023 Category: Cancer & Oncology Authors: Ya-Ting Huang Tom Wei-Wu Chen Li-Yu Chen Ya-Yao Huang Yen-Shen Lu Source Type: research
The Application of 18F-FES PET in Clinical Cancer Care: A Systematic Review
CONCLUSIONS: [18F]fluoroestradiol PET is not only a convenient and accurate diagnostic imaging tool for detecting ER-expressing lesions in patients with breast and ovarian cancer but also among patients with uterine cancer. [18F]fluoroestradiol PET is a noninvasive predictive and monitoring tool for treatment response and prognosis.PMID:37482660 | DOI:10.1097/RLU.0000000000004760 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - July 24, 2023 Category: Cancer & Oncology Authors: Ya-Ting Huang Tom Wei-Wu Chen Li-Yu Chen Ya-Yao Huang Yen-Shen Lu Source Type: research
The Application of 18F-FES PET in Clinical Cancer Care: A Systematic Review
CONCLUSIONS: [18F]fluoroestradiol PET is not only a convenient and accurate diagnostic imaging tool for detecting ER-expressing lesions in patients with breast and ovarian cancer but also among patients with uterine cancer. [18F]fluoroestradiol PET is a noninvasive predictive and monitoring tool for treatment response and prognosis.PMID:37482660 | DOI:10.1097/RLU.0000000000004760 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - July 24, 2023 Category: Cancer & Oncology Authors: Ya-Ting Huang Tom Wei-Wu Chen Li-Yu Chen Ya-Yao Huang Yen-Shen Lu Source Type: research
The Application of 18F-FES PET in Clinical Cancer Care: A Systematic Review
CONCLUSIONS: [18F]fluoroestradiol PET is not only a convenient and accurate diagnostic imaging tool for detecting ER-expressing lesions in patients with breast and ovarian cancer but also among patients with uterine cancer. [18F]fluoroestradiol PET is a noninvasive predictive and monitoring tool for treatment response and prognosis.PMID:37482660 | DOI:10.1097/RLU.0000000000004760 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - July 24, 2023 Category: Cancer & Oncology Authors: Ya-Ting Huang Tom Wei-Wu Chen Li-Yu Chen Ya-Yao Huang Yen-Shen Lu Source Type: research
